胃食管反流病的无创监测指标及诊断评分临床应用的研究进展
Research Progress in the Clinical Application of Non-Invasive Monitoring Indexes and Diagnostic Scores for Gastroesophageal Reflux Disease
DOI: 10.12677/acm.2024.14113018, PDF,   
作者: 龚 欢, 赵婷婷, 黄 梦, 刘成成, 贺 娜*:西安医学院研究生工作部,陕西 西安;西安医学院第一附属医院消化二病区,陕西 西安
关键词: 胃食管反流病无创监测诊断评分研究进展Gastroesophageal Reflux Disease Non-Invasive Monitoring Diagnostic Score Research Progress
摘要: 胃食管反流病(gastroesophageal reflux disease, GERD)是一种常见的慢性消化系统疾病,严重影响患者的生活质量。对于胃食管反流病的诊断和疗效判断,目前临床上以常规应用胃镜和24小时pH-阻抗的结果进行判断,但二者都为有创检查,患者耐受度较差,且在基层医院无法进行。胃食管反流病的主要治疗目的是缓解症状并提高患者的生活质量。因此,无创监测和有效的症状评估是至关重要的。基于此,本文总结目前胃食管反流病的无创监测指标以及诊断评分的研究进展,为临床医师在临床工作中诊断胃食管反流病和评估疗效提供参考。
Abstract: Gastroesophageal reflux disease (GERD) is a common chronic digestive disease, which can seriously affect the quality of life of patients. For the diagnosis and efficacy judgment of gastroesophageal reflux disease, gastroscopy and 24-hour pH-impedance results have been routinely used clinically, but both of them are invasive examinations with poor patient tolerance and cannot be performed in primary hospitals. The primary therapeutic goal of GERD is to relieve symptoms and restore a healthy quality of life; therefore, non-invasive monitoring and effective symptom evaluation are essential. Based on this, this paper summarizes the current research progress of non-invasive monitoring indicators and diagnostic scores of GERD, providing references for primary clinicians to diagnose GERD and evaluate therapeutic effects in clinical work.
文章引用:龚欢, 赵婷婷, 黄梦, 刘成成, 贺娜. 胃食管反流病的无创监测指标及诊断评分临床应用的研究进展[J]. 临床医学进展, 2024, 14(11): 1328-1336. https://doi.org/10.12677/acm.2024.14113018

参考文献

[1] Vakil, N., van Zanten, S.V., Kahrilas, P., Dent, J. and Jones, R. (2006) The Montreal Definition and Classification of Gastroesophageal Reflux Disease: A Global Evidence-Based Consensus. The American Journal of Gastroenterology, 101, 1900-1920. [Google Scholar] [CrossRef] [PubMed]
[2] Liu, Z., Gao, X., Liang, L., Zhou, X., Han, X., Yang, T., et al. (2023) Prevalence, General and Periodontal Risk Factors of Gastroesophageal Reflux Disease in China. Journal of Inflammation Research, 16, 235-244. [Google Scholar] [CrossRef] [PubMed]
[3] Dean, B.B., Crawley, J.A., Schmitt, C.M., Wong, J. and Ofman, J.J. (2003) The Burden of Illness of Gastro‐Oesophageal Reflux Disease: Impact on Work Productivity. Alimentary Pharmacology & Therapeutics, 17, 1309-1317. [Google Scholar] [CrossRef] [PubMed]
[4] Ghisa, M., Marinelli, C., Savarino, V. and Savarino, E. (2019) Idiopathic Pulmonary Fibrosis and GERD: Links and Risks. Therapeutics and Clinical Risk Management, 15, 1081-1093. [Google Scholar] [CrossRef] [PubMed]
[5] Gyawali, C.P., Yadlapati, R., Fass, R., Katzka, D., Pandolfino, J., Savarino, E., et al. (2023) Updates to the Modern Diagnosis of GERD: Lyon Consensus 2.0. Gut, 73, 361-371. [Google Scholar] [CrossRef] [PubMed]
[6] Juan Cai, W., Yin, L., Kang, Q., Chen Zeng, Z., Liang Wang, S. and Cheng, J. (2017) The Serum Pepsinogen Test as a Predictor of Kazakh Gastric Cancer. Scientific Reports, 7, Article No. 43536. [Google Scholar] [CrossRef] [PubMed]
[7] Qin, Y., Geng, J. and Huang, B. (2023) Clinical Value of Serum Pepsinogen in the Diagnosis and Treatment of Gastric Diseases. World Journal of Gastrointestinal Oncology, 15, 1174-1181. [Google Scholar] [CrossRef] [PubMed]
[8] Niv, Y. and Fass, R. (2011) The Role of Mucin in GERD and Its Complications. Nature Reviews Gastroenterology & Hepatology, 9, 55-59. [Google Scholar] [CrossRef] [PubMed]
[9] 张帅. 血清胃蛋白酶原、胃泌素17水平与胃食管反流病关系的研究[D]: [硕士学位论文]. 石家庄: 河北医科大学, 2022.
[10] 胥淑婷, 王娟, 张宝珍. 血清胃蛋白酶原Ⅰ、胃蛋白酶原Ⅱ及胃泌素17水平在胃食管反流病诊断中的价值研究[J]. 大医生, 2024, 9(6): 31-34.
[11] Wang, J., Zhao, Y., Ren, J. and Xu, Y. (2017) Pepsin in Saliva as a Diagnostic Biomarker in Laryngopharyngeal Reflux: A Meta-analysis. European Archives of Oto-Rhino-Laryngology, 275, 671-678. [Google Scholar] [CrossRef] [PubMed]
[12] Wang, Y., Lang, X., Wu, D., He, Y., Lan, C., Xiao, X., et al. (2020) Salivary Pepsin as an Intrinsic Marker for Diagnosis of Sub-Types of Gastroesophageal Reflux Disease and Gastroesophageal Reflux Disease-Related Disorders. Journal of Neurogastroenterology and Motility, 26, 74-84. [Google Scholar] [CrossRef] [PubMed]
[13] Woodland, P., Singendonk, M.M.J., Ooi, J., Nikaki, K., Wong, T., Lee, C., et al. (2019) Measurement of Salivary Pepsin to Detect Gastroesophageal Reflux Disease Is Not Ready for Clinical Application. Clinical Gastroenterology and Hepatology, 17, 563-565. [Google Scholar] [CrossRef] [PubMed]
[14] Bobin, F., Journe, F. and Lechien, J.R. (2019) Saliva Pepsin Level of Laryngopharyngeal Reflux Patients Is Not Correlated with Reflux Episodes. The Laryngoscope, 130, 1278-1281. [Google Scholar] [CrossRef] [PubMed]
[15] Straathof, J.W.A., Lamers, C.B.H.W. and Masclee, A.A.M. (1997) Effect of Gastrin-17 on Lower Esophageal Sphincter Characteristics in Man. Digestive Diseases and Sciences, 42, 2547-2551. [Google Scholar] [CrossRef] [PubMed]
[16] Sawada, M. and Dickinson, C.J. (1997) The G Cell. Annual Review of Physiology, 59, 273-298. [Google Scholar] [CrossRef] [PubMed]
[17] 陈立柱, 刘嘉. 胃食管反流病相关检验项目及诊断研究[J]. 中国医学装备, 2019, 16(2): 135-139.
[18] Sirchak, Y.S., Kydybyts, S.S., Bedey, N.V., Chendey, V.I., Stan, M.P. and Chobej, S.M. (2023) Changes in Serum Somatostatin and Gastrin Levels in Patients after Cholecystectomy and Gastroesophageal Reflux Disease. Wiadomości Lekarskie, 76, 548-553. [Google Scholar] [CrossRef] [PubMed]
[19] Di Mario, F., Crafa, P., Franceschi, M., Rodriguez-Castro, K., Baldassarre, G., Ferronato, A., et al. (2021) Low Levels of Gastrin 17 Are Related with Endoscopic Findings of Esophagitis and Typical Symptoms of GERD. Journal of Gastrointestinal and Liver Diseases, 30, 25-29. [Google Scholar] [CrossRef] [PubMed]
[20] Zahorec, R. (2021) Neutrophil-to-lymphocyte Ratio, Past, Present and Future Perspectives. Bratislava Medical Journal, 122, 474-488. [Google Scholar] [CrossRef] [PubMed]
[21] 黎鑫, 艾克拜尔∙艾力, 阿力木江∙麦斯依提, 等. 外周血WBC和NLR对肥胖症合并胃食管反流病的临床诊断价值[J]. 解放军医学杂志, 2023, 48(10): 1180-1185.
[22] 王海明, 徐莉敏, 田涛, 等. 中性粒细胞与淋巴细胞比值与反流性食管炎严重程度的相关性研究[J]. 中国研究型医院, 2021, 8(6): 57-61.
[23] 徐晓娟, 刘姝, 郭万玉. 观察胃功能三项检测对胃食管反流病(GERD)患者使用质子泵抑制剂治疗的临床效果[J]. 黑龙江医药, 2023, 36(1): 123-125.
[24] 陈彦文, 李为光, 姚玮艳, 等. NRF2/HO-1通路在阿司匹林相关胃黏膜上皮细胞损伤机制中的作用[J]. 内科理论与实践, 2019, 14(4): 247-252.
[25] 吾布力卡斯木∙吾拉木, 买买提∙依斯热依力, 克力木∙阿不都热依木. 慢性束缚应激对小鼠食管内脏敏感性的影响及其诱导食管炎症和氧化应激的作用[J]. 中华医学杂志, 2019, 99(2): 135-141.
[26] 辛丽娟, 熊文生. 反流性食管炎患者血清血红素氧合酶-1、谷胱甘肽表达及临床意义[J]. 中国临床医生杂志, 2022, 50(4): 434-437.
[27] 吴建兵, 黄张建, 张奕华. 一氧化氮供体型心脑血管药物研究的实践与思考[J]. 中国药科大学学报, 2021, 52(2): 129-143.
[28] Grisham, M.B., Jourd’Heuil, D. and Wink, D.A. (1999) I. Physiological Chemistry of Nitric Oxide and Its Metabolites: Implications in Inflammation. American Journal of Physiology-Gastrointestinal and Liver Physiology, 276, G315-G321. [Google Scholar] [CrossRef] [PubMed]
[29] 赵继先, 魏红山. 一氧化氮合酶不同亚型在食管上皮的表达及其与胃食管反流病的相关性[J]. 临床输血与检验, 2019, 21(6): 633-637.
[30] Biggemann, L., Uhlig, J., Gliem, N., Al-Bourini, O., Wedi, E., Ellenrieder, V., et al. (2021) Assessment of Esophagogastric Junction Morphology by Dynamic Real-Time MRI: Comparison of Imaging Features to High-Resolution Manometry. Japanese Journal of Radiology, 40, 376-384. [Google Scholar] [CrossRef] [PubMed]
[31] Uecker, M., Zhang, S., Voit, D., Karaus, A., Merboldt, K. and Frahm, J. (2010) Real‐Time MRI at a Resolution of 20 Ms. NMR in Biomedicine, 23, 986-994. [Google Scholar] [CrossRef] [PubMed]
[32] Biggemann, L., Uhlig, J., Streit, U., Al-Bourini, O., Wedi, E., Amanzada, A., et al. (2023) Visualization of Deglutition and Gastroesophageal Reflux Using Real-Time MRI: A Standardized Approach to Image Acquisition and Assessment. Scientific Reports, 13, Article No. 22854. [Google Scholar] [CrossRef] [PubMed]
[33] Seif Amir Hosseini, A., Uhlig, J., Streit, U., Gliem, N., Wedi, E., Ellenrieder, V., et al. (2020) Real-Time MRI for Dynamic Assessment of Gastroesophageal Reflux Disease: Comparison to Ph-Metry and Impedance. European Journal of Radiology, 125, Article ID: 108856. [Google Scholar] [CrossRef] [PubMed]
[34] Seif Amir Hosseini, A., Uhlig, J., Streit, U., Voit, D., Uhlig, A., Ellenrieder, V., et al. (2019) Real-Time MRI for the Dynamic Assessment of Fundoplication Failure in Patients with Gastroesophageal Reflux Disease. European Radiology, 29, 4691-4698. [Google Scholar] [CrossRef] [PubMed]
[35] Seif Amir Hosseini, A., Uhlig, J., Streit, U., Uhlig, A., Sprenger, T., Wedi, E., et al. (2019) Hiatal Hernias in Patients with GERD-Like Symptoms: Evaluation of Dynamic Real-Time MRI vs Endoscopy. European Radiology, 29, 6653-6661. [Google Scholar] [CrossRef] [PubMed]
[36] 吴超. 食管实时MRI在胃食管反流病中的应用进展[J]. 国际医学放射学杂志, 2022, 45(1): 80-83.
[37] 曹海明, 李昌平. 超声造影诊断胃食管反流病的研究进展[J]. 现代临床医学, 2022, 48(6): 458-460.
[38] 涂颖. 混合超声造影对胃食管反流病的诊断价值研究[D]: [硕士学位论文]. 泸州: 西南医科大学, 2023.
[39] 彭利, 王竞宇, 罗燕, 等. 口服声诺维微泡超声增强剂与胃助显剂混合液对胃食管反流病的诊断效能[J]. 西部医学, 2020, 32(4): 562-566.
[40] 谢春艳, 彭利, 邓巍, 等. 基层医院胃镜下食管阀瓣分级联合食管胃超声造影对胃食管反流病的诊断价值[J]. 四川医学, 2023, 44(8): 800-805.
[41] 邢益民, 张天飞, 戴慧勇. 胃肠充盈超声造影检查在反酸、嗳气患者临床诊断中的应用[J]. 中华普外科手术学杂志(电子版), 2024, 18(3): 303-306.
[42] 彭利, 王竞宇, 郑世成, 等. 胃充盈超声造影与内镜检查对胃食管反流病的诊断价值[J]. 西部医学, 2019, 31(10): 1613-1616.
[43] 中华医学会消化病学分会. 2020年中国胃食管反流病专家共识[J]. 中华消化杂志, 2020, 40(10): 649-663.
[44] 肖英莲, 陈旻湖. 胃食管反流病诊断技术的进展[J]. 胃肠病学, 2008, 13(2): 76-78.
[45] Chinese GERD Study Group (2004) Value of Reflux Diagnostic Questionnaire in the Diagnosis of Gastroesophageal Reflux Disease. Chinese Journal of Digestive Diseases, 5, 51-55. [Google Scholar] [CrossRef] [PubMed]
[46] 中国胃食管反流病研究协作组. 反流性疾病问卷在胃食管反流病诊断中的价值[J]. 中华消化杂志, 2003, 23(11): 651-654.
[47] Jung, H., Choi, M., Baek, M. and Wu, J.C.Y. (2018) Development and Psychometric Assessment of a Self-Evaluation Questionnaire for Gastroesophageal Reflux Disease. Journal of Neurogastroenterology and Motility, 24, 584-592. [Google Scholar] [CrossRef] [PubMed]
[48] Jones, R., Junghard, O., Dent, J., Vakil, N., Halling, K., Wernersson, B., et al. (2009) Development of the GerdQ, a Tool for the Diagnosis and Management of Gastro‐Oesophageal Reflux Disease in Primary Care. Alimentary Pharmacology & Therapeutics, 30, 1030-1038. [Google Scholar] [CrossRef] [PubMed]
[49] Thomas, E., Wade, A., Crawford, G., Jenner, B., Levinson, N. and Wilkinson, J. (2014) Randomised Clinical Trial: Relief of Upper Gastrointestinal Symptoms by an Acid Pocket‐Targeting Alginate—Antacid (Gaviscon Double Action) —A Double‐Blind, Placebo‐Controlled, Pilot Study in Gastro‐Oesophageal Reflux Disease. Alimentary Pharmacology & Therapeutics, 39, 595-602. [Google Scholar] [CrossRef] [PubMed]
[50] Sugihartono, T., Hidayat, A.A., Lusida, M.A.P., Kuntaman,, Aftab, H. and Miftahussurur, M. (2023) Comparison of RDQ and GerdQ for Predicting Erosive Esophagitis in Patients with Typical GERD Symptoms. The Korean Journal of Gastroenterology, 82, 84-90. [Google Scholar] [CrossRef] [PubMed]
[51] GerdQ研究协作组. 胃食管反流病问卷对胃食管反流病的诊断价值[J]. 中华消化杂志, 2009, 29(12): 793-798.
[52] Aili, A., Maimaitiming, M., Maimaitiyusufu, P., Tusuntuoheti, Y., Li, X., Cui, J., et al. (2022) Gastroesophageal Reflux Related Changes after Sleeve Gastrectomy and Sleeve Gastrectomy with Fundoplication: A Retrospective Single Center Study. Frontiers in Endocrinology, 13, Article 1041889. [Google Scholar] [CrossRef] [PubMed]
[53] Sui, X., Gao, X., Zhang, L., Zhang, B., Zhong, C., Chen, Y., et al. (2022) Clinical Efficacy of Endoscopic Antireflux Mucosectomy vs. Stretta Radiofrequency in the Treatment of Gastroesophageal Reflux Disease: A Retrospective, Single-Center Cohort Study. Annals of Translational Medicine, 10, Article 660. [Google Scholar] [CrossRef] [PubMed]
[54] Lu, D., Bi, C.S., Wei, X., Guo, B.N., Gao, Y.X., Chen, J., et al. (2021) A Retrospective Study of the Safety and Efficacy of Endoscopic Radiofrequency Therapy under Direct Vision in 59 Patients with Gastroesophageal Reflux Disease from 2 Centers in Beijing, China Using the Gastroesophageal Reflux Disease Questionnaire. Medical Science Monitor, 28, e933848. [Google Scholar] [CrossRef] [PubMed]
[55] Bai, Y., Du, Y., Zou, D., Jin, Z., Zhan, X., Li, Z., et al. (2013) Gastroesophageal Reflux Disease Questionnaire (GerdQ) in Real‐World Practice: A National Multicenter Survey on 8065 Patients. Journal of Gastroenterology and Hepatology, 28, 626-631. [Google Scholar] [CrossRef] [PubMed]
[56] Velanovich, V. (1998) Comparison of Generic (SF-36) Vs. Disease-Specific (GERD-HRQL) Quality-of-Life Scales for Gastroesophageal Reflux Disease. Journal of Gastrointestinal Surgery, 2, 141-145. [Google Scholar] [CrossRef] [PubMed]
[57] Zhuang, Q., Liao, A., He, Q., Liu, C., Zheng, C., Li, X., et al. (2024) The Efficacy and Safety of Fexuprazan in Treating Erosive Esophagitis: A Phase III, Randomized, Double‐Blind, Multicenter Study. Journal of Gastroenterology and Hepatology, 39, 658-666. [Google Scholar] [CrossRef] [PubMed]
[58] Kim, S.E. (2024) Long-term Efficacy of Endoscopic Radiofrequency Stretta Therapy for Patients with Refractory Gastroesophageal Reflux Disease. Clinical Endoscopy, 57, 48-50. [Google Scholar] [CrossRef] [PubMed]
[59] DeWitt, J.M., Al-Haddad, M., Stainko, S., Perkins, A., Fatima, H., Ceppa, D.P., et al. (2023) Transoral Incisionless Fundoplication with or without Hiatal Hernia Repair for Gastroesophageal Reflux Disease after Peroral Endoscopic Myotomy. Endoscopy International Open, 12, E43-E49. [Google Scholar] [CrossRef] [PubMed]
[60] Shen, S., Yu, G., Guo, X., Zong, G., Wang, C., Bao, J., et al. (2023) The Long-Term Efficacy of Transoral Incisionless Fundoplication with Medigus Ultrasonic Surgical Endostapler (MUSE) for Gastroesophageal Reflux Disease. Esophagus, 20, 581-586. [Google Scholar] [CrossRef] [PubMed]
[61] Rothman, M., Farup, C., Stewart, W., Helbers, L. and Zeldis, J. (2001) Symptoms Associated with Gastroesophageal Reflux Disease: Development of a Questionnaire for Use in Clinical Trials. Digestive Diseases and Sciences, 46, 1540-1549. [Google Scholar] [CrossRef] [PubMed]
[62] Gu, C., Olszewski, T., King, K.L., Vaezi, M.F., Niswender, K.D. and Silver, H.J. (2022) The Effects of Modifying Amount and Type of Dietary Carbohydrate on Esophageal Acid Exposure Time and Esophageal Reflux Symptoms: A Randomized Controlled Trial. American Journal of Gastroenterology, 117, 1655-1667. [Google Scholar] [CrossRef] [PubMed]
[63] Damiano, A., Handley, K., Adler, E., Siddique, R. and Bhattacharyja, A. (2002) Measuring Symptom Distress and Health-Related Quality of Life in Clinical Trials of Gastroesophageal Reflux Disease Treatment: Further Validation of the Gastroesophageal Reflux Disease Symptom Assessment Scale (GSAS). Digestive Diseases and Sciences, 47, 1530-1537. [Google Scholar] [CrossRef] [PubMed]